Whether or not the above points are a consensus for all areas of the supply chain are of course debatable, but either way, one thing that came out of the discussions was that pharma has more significant and less quantifiable barriers to address than others, particularly in broader digital transformation initiatives. These barriers include:
- Legislation and compliance
- Culture changes (training, attitude, motivation etc.)
- Policy and organisational change
- Stakeholder agreement\adoption
- Mindset changes
These themes are common across many sectors, but a reoccurring opinion that I came across was that as an industry pharma has traditionally been relatively more introspective and risk-averse, making a strong case for collaborating with more nimble outfits.